The global gastroenteritis treatment market size was valued at USD 44.18 billion in 2025 and is expected to reach USD 70.41 billion by 2033, at a CAGR of 6.00% during the forecast period
The market growth is primarily driven by the high global incidence of infectious gastroenteritis caused by viral, bacterial, and parasitic pathogens, particularly in regions with limited access to clean water and sanitation infrastructure
Furthermore, increasing awareness regarding early diagnosis and treatment, along with rising healthcare access, oral rehydration therapy adoption, and improved availability of antibiotics and antivirals, is supporting market expansion and strengthening demand for effective gastroenteritis management solutions
6 Views